Primary efficacy endpoint
Ocular hypotensive
At the upper limit of the 95% CI difference, IOP ≤ 1.5 mmHg was achieved at all nine time points and ≤ 1.0 mmHg at the majority (six out of nine) of time points from Week 2 through Month 3 (Fig. Ocular hypotensive efficacy assessed by mean IOP at Week 2, Week 6 and Month 3. *